IIL to invest Rs 700 crore on it greenfield veterinary vaccine facility in Hyderabad’s Genome Valley – ET HealthWorld | Pharma

Hyderabad: Indian Immunologicals Limited ,IIL) on Thursday announced that it has started construction of its new greenfield veterinary vaccine facility to manufacture the Foot and Mouth Disease Vaccine (FMD-Vac) as well as Foot and Mouth Disease + Haemorrhagic Septicemia Vaccine (FMD+HS-Vac) in Hyderabad’s Genome valley.

This brand-new unit will have a BSL3 facility for the manufacturing of Drug substances and a Fill-Finish capability for the production of both drug products. FMD vaccine and the FMD+HS vaccine.

Telangana State Industrial Infrastructure Corporation Ltd (TSIIC), a Government of Telangana undertaking, had allotted the land to IIL at Biotech Park, Phase III, Karkapatla, Siddipet district in Telangana. The proposed facility has a capacity of 150 million doses/annum of FMD vaccine and 150 million doses/annum of FMD+HS vaccine each. With an investment of approximately INR 700 Cr, the proposed facility is expected to create more than 750 direct and indirect jobs.

Speaking on the occasion, Dr Meenesh Shah, Chairman of NDDB and IIL said, “IIL continues to fulfill the purpose for which it was created by NDDB as a world-class vaccine manufacturer. This new vaccine manufacturing facility in Hyderabad is dedicated to the nation and will certainly aid in the eradication of Foot and Mouth Disease in our country. IIL’s ability to discover and manufacture affordable vaccines has saved the exchequer several thousand crores of rupees”.

Dr K Anand Kumar, Managing Director, IIL said, “We are the largest supplier of FMD vaccine to Government of India’s prestigious Livestock Health Disease Control Program (LHDCP). We are in an exponential growth phase and expected to grow 40 per cent this year alone. In order to sustain the momentum, IIL is seriously considering making additional investments in building infrastructure within India and in other emerging geographies including Africa in a manner to develop tools that will help in control and eradication of diseases.”

  • Published On Dec 28, 2023 at 05:38 PM IST

Join the community of 2M+ industry professionals

Subscribe to our newsletter to get latest insights & analysis.

Download ETHealthworld App

  • Get realtime updates
  • Save your favorite articles

Scan to download App

Leave a Comment